Identification of cysteines involved in the effects of methanethiosulfonate reagents on human equilibrative nucleoside transporter 1

Molecular Pharmacology

Volumn 80, Issue 4, 2011, Pages 735-746

  Park, Jamie S ^a   Hughes, Scott J ^a   Cunningham, Frances K M ^a   Hammond, James R ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; 2 CHLOROADENOSINE H 3; [2(TRIMETHYLAMMONIUM)ETHYL] METHANE THIOSULFATE; CYSTEINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; NITROBENZYLTHIOINOSINE; REAGENT; SERINE; SODIUM (2 SULFONATOETHYL) METHANETHIOSULFATE; THIOMESYLIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MUTANT; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYSTEINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; HUMANS; INDICATORS AND REAGENTS; MESYLATES; MOLECULAR SEQUENCE DATA; MUTATION; SWINE;

EID: 80053203339     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.072587     Document Type: Article

References (39)

1. Akabas MH, Stauffer DA, Xu M, and Karlin A (1992) Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258:307-310.
2. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, and Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447:735-743. (Pubitemid 38241459)
3. Belt JA (1983) Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Mol Pharmacol 24:479-484.
4. Belt JA, Marina NM, Phelps DA, and Crawford CR (1993) Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 33:235-252. (Pubitemid 223051922)
5. Bone DB, Choi DS, Coe IR, and Hammond JR (2010) Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/-mice. Am J Physiol Heart Circ Physiol 299:H847-H856.
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Chen JG, Sachpatzidis A, and Rudnick G (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327. (Pubitemid 27517776)
8. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
9. Dahlig-Harley E, Eilam Y, Paterson AR, and Cass CE (1981) Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside transport mechanism of HeLa cells. Biochem J 200:295-305. (Pubitemid 12218252)
10. Endres CJ, Sengupta DJ, and Unadkat JD (2004) Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)- mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1. Biochem J 380:131-137. (Pubitemid 38725737)
11. Endres CJ and Unadkat JD (2005) Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole. Mol Pharmacol 67: 837-844. (Pubitemid 40365331)
12. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153-181. (Pubitemid 26426520)
13. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, and Baldwin SA (1997) Molecular cloning and characterization of a nitrobenzylthioinosineinsensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328:739-743. (Pubitemid 28005769)
14. Hyde RJ, Cass CE, Young JD, and Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63. (Pubitemid 32521597)
15. Jarvis SM, Hammond JR, Paterson AR, and Clanachan AS (1982) Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes. Biochem J 208:83-88. (Pubitemid 13215399)
16. Jarvis SM and Young JD (1980) Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. Biochem J 190:377-383. (Pubitemid 11245808)
17. Jarvis SM and Young JD (1982) Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter. J Physiol 324:47-66. (Pubitemid 12132463)
18. Jarvis SM and Young JD (1986) Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate. J Membr Biol 93:1-10. (Pubitemid 17176520)
19. Karlin A and Akabas MH (1998) Substituted-cysteine accessibility method. Methods Enzymol 293:123-145. (Pubitemid 29342485)
20. Kong W, Engel K, and Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63-84. (Pubitemid 38279408)
21. Krzystyniak K, Fournier M, and Ryzewski J (1988) N-Ethylmaleimide differentially affects adenosine and thymidine uptake by rat thymocytes. Arch Immunol Ther Exp (Warsz) 36:287-294. (Pubitemid 19065308)
22. Lambert G, Forster IC, Biber J, and Murer H (2000) Cysteine residues and the structure of the rat renal proximal tubular type II sodium phosphate cotransporter (rat NaPi IIa). J Membr Biol 176:133-141. (Pubitemid 30609837)
23. Lee CW, Goh LB, and Tu Y (1995) Sensitivity to inhibition by N-ethylmaleimide: a property of nitrobenzylthioinosine-sensitive equilibrative nucleoside transporter of murine myeloma cells. Biochim Biophys Acta 1268:200-208.
24. Löffler M, Morote-Garcia JC, Eltzschig SA, Coe IR, and Eltzschig HK (2007) Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 27:1004-1013. (Pubitemid 46641985)
25. Paproski RJ, Young JD, and Cass CE (2010) Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′-fluorothymidine. Biochem Pharmacol 79:587-595.
26. Plagemann PG and Richey DP (1974) Transport of nucleosides, nucleic acid bases, choline and glucose by animal cells in culture. Biochim Biophys Acta 344:263-305.
27. 2+exchanger NCX1 expressed in HEK 293 cells is sensitive to covalent modification of intracellular cysteine residues by sulfhydryl reagents. J Biol Chem 276:9572- 9579.
28. SenGupta DJ, Lum PY, Lai Y, Shubochkina E, Bakken AH, Schneider G, and Unadkat JD (2002) A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry 41:1512-1519. (Pubitemid 34112740)
29. SenGupta DJ and Unadkat JD (2004) Glycine 154 of the equilibrative nucleoside transporter, HENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. Biochem Pharmacol 67:453-458. (Pubitemid 38232885)
30. Sundaram M, Yao SY, Ingram JC, Berry ZA, Abidi F, Cass CE, Baldwin SA, and Young JD (2001a) Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J Biol Chem 276:45270-45275.
31. Sundaram M, Yao SY, Ng AM, Cass CE, Baldwin SA, and Young JD (2001b) Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins. Biochemistry 40:8146-8151. (Pubitemid 32641212)
32. Sundaram M, Yao SY, Ng AM, Griffiths M, Cass CE, Baldwin SA, and Young JD (1998) Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem 273:21519-21525. (Pubitemid 28405320)
33. Tse CM, Wu JS, and Young JD (1985) Evidence for the asymmetrical binding of p-chloromercuriphenyl sulphonate to the human erythrocyte nucleoside transporter. Biochim Biophys Acta 818:316-324.
34. Vyas S, Ahmadi B, and Hammond JR (2002) Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide. Arch Biochem Biophys 403:92-102. (Pubitemid 34848282)
35. Ward JL, Sherali A, Mo ZP, and Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381. (Pubitemid 30180179)
36. Xu W, Chen C, Huang P, Li J, De Riel JK, Javitch JA, and Liu-Chen LY (2000) The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors. Biochemistry 39:13904-13915.
37. Yao SY, Ng AM, Vickers MF, Sundaram M, Cass CE, Baldwin SA, and Young JD (2002) Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277:24938-24948. (Pubitemid 34951795)
38. Young JD and Jarvis SM (1985) The use of ligands in the study of the nucleosidetransport complex, in Methods in Pharmacology (Paton DM ed) pp 181-190, Plenum Press, New York.
39. Zhang J, Visser F, King KM, Baldwin SA, Young JD, and Cass CE (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev 26:85-110. (Pubitemid 46452184)